Managing Pediatric Drug-Induced Dyspepsia with H2 Receptor Antagonists (H2RAs): Indian Paediatricians' Perspectives Dr. Bhumika Maikhuri12 March 2026 10:30 AM ISTDrugs are identified as a frequent cause of new-onset dyspeptic symptoms, like upper abdominal pain, early sense of satiety, epigastric discomfort...
Managing GERD in Children with Asthma with H2 receptor antagonists (H2RAs): Indian Paediatricians' Perspectives Dr. Garima Soni5 Dec 2025 12:30 PM ISTGastroesophageal reflux disease (GERD) symptoms extend beyond typical esophageal symptoms such as heartburn and regurgitation, with asthma emerging...
H2 receptor antagonists (H2RAs) in Gastrointestinal Care of Neonates and Infants: Indian Paediatricians' Perspectives Dr. Garima Soni8 Nov 2025 11:50 AM ISTGastrointestinal (GI) conditions are common in neonates and infants. These may include Gastroesophageal Reflux (GER), Gastroesophageal Reflux...
Prediabetes and MASLD : An Overlapping Spectrum of Metabolic Risk Dr. Anusha N D14 July 2025 11:01 AM ISTConverging Burden of Prediabetes and MASLD: Prediabetes is associated with a nearly 4-fold higher risk of MASLD. (1) Approximately 33% of Indian...
Association of Physicians of India Consensus Recommendations for Vonoprazan in Management of Acid Peptic Disorders Dr. Kamal Kant Kohli26 March 2025 11:36 AM ISTThe Association of Physicians of India (API) has recently issued a consensus statement, highlighting vonoprazan as an effective option for managing...
Postprandial Reflux-Indian Issues, Challenges, and Management with a focus on Sodium Alginate Dr Surakshith T K23 Aug 2024 11:30 AM ISTPost-meal reflux, also known as postprandial reflux, refers to the regurgitation of stomach contents into the esophagus following a meal. (1). It is...
Bedtime Ranitidine for Nighttime Acid Reflux: Choose your Option Wisely! Dr. Kamal Kant Kohli15 Feb 2024 11:45 AM ISTNighttime acid reflux commonly referred to as nocturnal acid breakthrough (NAB) is defined as a persistent decrease in intragastric pH below 4 for...
Considering Ranitidine in Episodic Heartburn Relief-A Practice Perspective Dr. Kamal Kant Kohli18 Jan 2024 11:14 AM ISTHeartburn is a cardinal symptom of gastroesophageal reflux disease (GERD). (1) It is defined as a sensation of burning discomfort in the chest, upper...
Potassium-Competitive Acid Blockers (P- CABs) for GERD Management - Potential Game Changer or Washout? Dr Jeegar Dattani7 Dec 2023 11:30 AM ISTProton pump Inhibitors have been used globally for the management of gastroesophageal disease (GERD) and Acid Peptic Disease (APD) for a long time....
Safety of Ranitidine: A Fresh Look at an Old Gem Dr. Kamal Kant Kohli23 Nov 2023 11:09 AM ISTThe introduction of histamine type 2 receptor antagonists (H2RAs) has revolutionised the management of acid-related disorders. Ranitidine has been...
Long-term PPI Use and Increased Cancer Risk: An Unrevealed Truth Dr. Kamal Kant Kohli2 Nov 2023 11:15 AM ISTReviewing Proton Pump Inhibitors:Proton pump inhibitors (PPIs) are commonly prescribed to reduce stomach acid levels in managing gastroesophageal...
Discourage Use of Proton Pump Inhibitors in Children Below 1 Year of Age: Guidelines from Indian Society of Gastroenterology Dr. Kamal Kant Kohli25 Sept 2023 11:15 AM ISTThe use of PPIs should be discouraged among children below 1 year of age, as per the latest Indian Guidelines recommending optimization with the use...
